Henner Stege

1.0k total citations
29 papers, 403 citations indexed

About

Henner Stege is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Henner Stege has authored 29 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Henner Stege's work include Melanoma and MAPK Pathways (6 papers), Cutaneous Melanoma Detection and Management (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Henner Stege is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), Cutaneous Melanoma Detection and Management (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Henner Stege collaborates with scholars based in Germany, United States and India. Henner Stege's co-authors include Stephan Grabbe, Matthias Bros, Maximilian Haist, Carmen Loquai, Mohamad Goldust, Claudine Graf, Wolfram Ruf, Michael H. Gold, Uwe Wollina and Anant Patil and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Henner Stege

25 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henner Stege Germany 9 196 194 89 36 34 29 403
Guy S. Missotten Netherlands 10 220 1.1× 107 0.6× 170 1.9× 41 1.1× 38 1.1× 16 548
Maximilian Haist Germany 9 192 1.0× 194 1.0× 95 1.1× 20 0.6× 29 0.9× 23 354
Shaheer Khan United States 11 257 1.3× 135 0.7× 113 1.3× 47 1.3× 70 2.1× 28 430
Xinyue Qi China 10 165 0.8× 137 0.7× 82 0.9× 11 0.3× 16 0.5× 25 296
Zhiding Wang China 15 106 0.5× 246 1.3× 142 1.6× 20 0.6× 14 0.4× 35 445
Gianluca Di Monta Italy 11 199 1.0× 98 0.5× 40 0.4× 90 2.5× 23 0.7× 28 422
Amanda Holstein United States 5 163 0.8× 206 1.1× 73 0.8× 16 0.4× 8 0.2× 8 342
Jasper F. Nies Germany 6 118 0.6× 121 0.6× 110 1.2× 42 1.2× 31 0.9× 11 309
Clara R. Farley United States 9 158 0.8× 76 0.4× 35 0.4× 43 1.2× 17 0.5× 22 255
Jin Soo Yoo United States 12 215 1.1× 67 0.3× 164 1.8× 48 1.3× 67 2.0× 24 443

Countries citing papers authored by Henner Stege

Since Specialization
Citations

This map shows the geographic impact of Henner Stege's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henner Stege with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henner Stege more than expected).

Fields of papers citing papers by Henner Stege

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henner Stege. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henner Stege. The network helps show where Henner Stege may publish in the future.

Co-authorship network of co-authors of Henner Stege

This figure shows the co-authorship network connecting the top 25 collaborators of Henner Stege. A scholar is included among the top collaborators of Henner Stege based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henner Stege. Henner Stege is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grabbe, Stephan, et al.. (2025). Cutaneous Squamous Cell Carcinoma Risk Factors: Are Current Criteria Still Valid? A Retrospective, Monocenter Analysis. Life. 15(8). 1257–1257. 1 indexed citations
2.
Klein, Matthias, Maximilian Haist, Tobias Sinnberg, et al.. (2025). Constitutive expression of the transcriptional co-activator IκBζ promotes melanoma growth and immunotherapy resistance. Nature Communications. 16(1). 5387–5387.
3.
Kippenberger, Stefan, Johannes Kleemann, Henner Stege, et al.. (2024). Exploring the Thoughts, Needs and Fears of Chemotherapy Patients—An Analysis Based on Google Search Behavior. Healthcare. 12(17). 1689–1689. 1 indexed citations
4.
5.
Lang, Berenice M., et al.. (2024). Wenn der Patient die Wahl hat – Therapiezufriedenheit und Patientenpräferenzen bei der Behandlung aktinischer Keratosen. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 22(10). 1362–1370.
6.
Kleemann, Johannes, Maximilian Haist, Henner Stege, et al.. (2024). The skin microbiome stratifies patients with cutaneous T cell lymphoma and determines event-free survival. npj Biofilms and Microbiomes. 10(1). 74–74. 4 indexed citations
7.
Lang, Berenice M., et al.. (2024). If patients had a choice – Treatment satisfaction and patients’ preference in therapy of actinic keratoses. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 22(10). 1362–1368. 4 indexed citations
8.
Lang, Berenice M., et al.. (2023). Seborrhoische Keratosen. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 21(3). 265–278.
9.
Salzmann, Martin, Alexander Wald, Henner Stege, et al.. (2023). Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study. Cancers. 15(5). 1426–1426. 1 indexed citations
10.
Haist, Maximilian, et al.. (2023). Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?. Cancer and Metastasis Reviews. 42(2). 481–505. 12 indexed citations
11.
Stege, Henner, et al.. (2023). Bridging the gaps: management of lichen planus subtypes in a joint dermatology–oral surgery clinic. Clinical and Experimental Dermatology. 49(1). 18–25. 3 indexed citations
12.
Lang, Berenice M., et al.. (2023). Seborrheic keratosis. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 21(3). 265–277. 5 indexed citations
13.
Raker, Verena, Detlef Becker, Matthias Bros, et al.. (2022). Protease‐ and cell type–specific activation of protease‐activated receptor 2 in cutaneous inflammation. Journal of Thrombosis and Haemostasis. 20(12). 2823–2836. 8 indexed citations
14.
Haist, Maximilian, et al.. (2022). Poliosis Is Associated with Response to Checkpoint-Inhibitor Therapy: A Case Report of Two Patients with Multifocal Metastatic Melanoma. SHILAP Revista de lepidopterología. 2(2). 307–316. 2 indexed citations
15.
16.
Stege, Henner, Maximilian Haist, Peter Mohr, et al.. (2021). Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study. Cancer Immunology Immunotherapy. 70(11). 3313–3322. 17 indexed citations
17.
Stege, Henner, et al.. (2021). The Status of Adjuvant and Neoadjuvant Melanoma Therapy, New Developments and Upcoming Challenges. Targeted Oncology. 16(5). 537–552. 19 indexed citations
18.
Stege, Henner, Meike Roskamp, Christian Langer, et al.. (2021). Complement-Opsonized Nano-Carriers Are Bound by Dendritic Cells (DC) via Complement Receptor (CR)3, and by B Cell Subpopulations via CR-1/2, and Affect the Activation of DC and B-1 Cells. International Journal of Molecular Sciences. 22(6). 2869–2869. 13 indexed citations
19.
Patil, Anant, Uwe Wollina, Michael H. Gold, et al.. (2021). New diagnostic and imaging technologies in dermatology. Journal of Cosmetic Dermatology. 20(12). 3782–3787. 23 indexed citations
20.
Pietsch, Michael, et al.. (2019). Anaphylaktische Reaktionen nach Tollwutimpfungen mit Sensibilisierung gegenüber Gelatine. Allergo Journal. 28(4). 18–21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guy S. Missotten Breakdown of academic impact, for papers by Maximilian Haist Breakdown of academic impact, for papers by Shaheer Khan Breakdown of academic impact, for papers by Xinyue Qi Breakdown of academic impact, for papers by Zhiding Wang Breakdown of academic impact, for papers by Gianluca Di Monta Breakdown of academic impact, for papers by Amanda Holstein Breakdown of academic impact, for papers by Jasper F. Nies Breakdown of academic impact, for papers by Clara R. Farley Breakdown of academic impact, for papers by Jin Soo Yoo
Rankless by CCL
2026